These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
920 related items for PubMed ID: 28396501
1. Mechanism of Progressive Heart Failure and Significance of Pulmonary Hypertension in Obstructive Hypertrophic Cardiomyopathy. Covella M, Rowin EJ, Hill NS, Preston IR, Milan A, Opotowsky AR, Maron BJ, Maron MS, Maron BA. Circ Heart Fail; 2017 Apr; 10(4):e003689. PubMed ID: 28396501 [Abstract] [Full Text] [Related]
2. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction. Schaff HV, Dearani JA, Ommen SR, Sorajja P, Nishimura RA. J Thorac Cardiovasc Surg; 2012 Feb; 143(2):303-9. PubMed ID: 22154797 [Abstract] [Full Text] [Related]
3. Outcome of Alcohol Septal Ablation in Mildly Symptomatic Patients With Hypertrophic Obstructive Cardiomyopathy: A Long-Term Follow-Up Study Based on the Euro-Alcohol Septal Ablation Registry. Veselka J, Faber L, Liebregts M, Cooper R, Januska J, Krejci J, Bartel T, Dabrowski M, Hansen PR, Almaas VM, Seggewiss H, Horstkotte D, Adlova R, Bundgaard H, Ten Berg J, Stables RH, Jensen MK. J Am Heart Assoc; 2017 May 16; 6(5):. PubMed ID: 28512112 [Abstract] [Full Text] [Related]
4. The results of operation in patients with hypertrophic cardiomyopathy and pulmonary hypertension. Stone CD, Hennein HA, McIntosh CL, Quyyumi AA, Greenberg GJ, Clark RE. J Thorac Cardiovasc Surg; 1990 Sep 16; 100(3):343-51; discussion 352. PubMed ID: 2391971 [Abstract] [Full Text] [Related]
5. Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure. Naeije R, Gerges M, Vachiery JL, Caravita S, Gerges C, Lang IM. Circ Heart Fail; 2017 Sep 16; 10(9):. PubMed ID: 28912263 [Abstract] [Full Text] [Related]
6. Can echocardiographic evaluation of cardiopulmonary hemodynamics decrease right heart catheterizations in end-stage heart failure patients awaiting transplantation? Kuppahally SS, Michaels AD, Tandar A, Gilbert EM, Litwin SE, Bader FM. Am J Cardiol; 2010 Dec 01; 106(11):1657-62. PubMed ID: 21094370 [Abstract] [Full Text] [Related]
9. Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy With Pulmonary Hypertension. Maron BA, Kleiner DE, Arons E, Wertheim BM, Sharma NS, Haley KJ, Samokhin AO, Rowin EJ, Maron MS, Rosing DR, Maron BJ. Chest; 2023 Mar 01; 163(3):678-686. PubMed ID: 36243062 [Abstract] [Full Text] [Related]
10. Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction. Vanderpool RR, Saul M, Nouraie M, Gladwin MT, Simon MA. JAMA Cardiol; 2018 Apr 01; 3(4):298-306. PubMed ID: 29541759 [Abstract] [Full Text] [Related]
11. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. Ralph-Edwards A, Woo A, McCrindle BW, Shapero JL, Schwartz L, Rakowski H, Wigle ED, Williams WG. J Thorac Cardiovasc Surg; 2005 Feb 01; 129(2):351-8. PubMed ID: 15678046 [Abstract] [Full Text] [Related]
13. Revisiting Pulmonary Hypertension in the Era of Temporary Mechanical Circulatory Support - Literature Review and Case-Based Discussion. Sharma S, Ruiz J, Paghdar S, Desai S, Goswami R. Transplant Proc; 2023 Dec 01; 55(10):2462-2469. PubMed ID: 37980253 [Abstract] [Full Text] [Related]
15. Limitations of right heart catheterization in the diagnosis and risk stratification of patients with pulmonary hypertension related to left heart disease: insights from a wireless pulmonary artery pressure monitoring system. Raina A, Abraham WT, Adamson PB, Bauman J, Benza RL. J Heart Lung Transplant; 2015 Mar 01; 34(3):438-47. PubMed ID: 25813770 [Abstract] [Full Text] [Related]
16. Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy. Schönbeck MH, Brunner-La Rocca HP, Vogt PR, Lachat ML, Jenni R, Hess OM, Turina MI. Ann Thorac Surg; 1998 May 01; 65(5):1207-14. PubMed ID: 9594839 [Abstract] [Full Text] [Related]
17. Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions. Gietzen FH, Leuner CJ, Obergassel L, Strunk-Mueller C, Kuhn H. Circulation; 2002 Jul 23; 106(4):454-9. PubMed ID: 12135945 [Abstract] [Full Text] [Related]
18. Long-term outcome of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: a Scandinavian multicenter study. Jensen MK, Almaas VM, Jacobsson L, Hansen PR, Havndrup O, Aakhus S, Svane B, Hansen TF, Køber L, Endresen K, Eriksson MJ, Jørgensen E, Amlie JP, Gadler F, Bundgaard H. Circ Cardiovasc Interv; 2011 Jun 23; 4(3):256-65. PubMed ID: 21540441 [Abstract] [Full Text] [Related]
19. Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization: analysis in a large patient population. Greiner S, Jud A, Aurich M, Hess A, Hilbel T, Hardt S, Katus HA, Mereles D. J Am Heart Assoc; 2014 Aug 21; 3(4):. PubMed ID: 25146706 [Abstract] [Full Text] [Related]
20. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis. Cam A, Goel SS, Agarwal S, Menon V, Svensson LG, Tuzcu EM, Kapadia SR. J Thorac Cardiovasc Surg; 2011 Oct 21; 142(4):800-8. PubMed ID: 21320709 [Abstract] [Full Text] [Related] Page: [Next] [New Search]